4-HYDROXY-2- METHYL-5-(PROPAN-2-YLIDENE)CYCLOHEX-3-ENECARBALDEHYDE FOR THE PREVENTION AND TREATMENT OF A COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASE
申请人:CESA ALLIANCE S.A.
公开号:US20150361020A1
公开(公告)日:2015-12-17
The present invention concerns a pharmaceutical compound having the Formula (1):
or a pharmaceutically acceptable salt thereof,
for use in the prevention or treatment of a cognitive, neurodegenerative or neuronal disorder or disease such as the Alzheimer Disease,
a pharmaceutical composition and a method of preparing a pharmaceutical composition.